What the company does
Innate Pharma S.A. operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and peripheral T-cell lymphoma; IPH4502, a novel and differentiated topoisomerase I inhibitor ADC conjugated to exatecan targeting Nectin-4; and Monalizumab, a dual checkpoint inhibitor that targets T Cells and NK Cells. It also develops IPH5201, a blocking antibody that is in Phase II clinical trials targeting the CD39 immunosuppressive pathway; IPH5301, an anti-CD73 antibody targeting …
What the weekly tape is saying
IPH closed the latest completed week at 1.56 EUR. The 4-week return is -10.2% and the 12-week return is 45.4%. Trend Signal is inactive, Market Dynamics is 0.95. Setup signature: Risk-first tape with a 34/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 1.45 EUR
- Vs Trend Line
- 7.9%
- Fair Value
- 1.97 EUR
- Vs Fair Value
- -20.8%
- 52W High
- 2.20 EUR
- 52W Low
- 1.03 EUR
- Drawdown
- -29.0%
- Range Position
- 45.5%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 0
- 52W Active Breadth
- 0.0%
- Sector Scope
- FR Healthcare
- Sector Rank
- 12 of 76
- Sector Percentile
- 85.3%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
FR Healthcare
- Tracked Peers
- 76
- 4W Rank
- 53 of 76
- Avg 1W
- -2.1%
- Avg 4W
- -5.9%
- Trend Breadth
- 28.9%
- Positive MD
- 48.7%
FR Biotechnology
- Tracked Peers
- 33
- 4W Rank
- 18 of 33
- Avg 1W
- -2.8%
- Avg 4W
- -11.9%
- Trend Breadth
- 27.3%
- Positive RS
- 21.2%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.95
- 4W MD Change
- 3033.4%
- Relative Strength
- -4.08
- 4W RS Change
- -140.6%
- Expectation
- Undecided
- Probability
- 46.89%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 636.5K
- 13W Average
- 2.3M
- 52W Average
- 1.3M
- Vs 13W
- 0.3x
- Vs 52W
- 0.5x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 13.8%
- 52W Volatility
- 8.7%
- Upside Weeks
- 25
- Downside Weeks
- 26
- Downside Breadth
- 50.0%
- Avg Gain / Loss
- 6.5% / -5.8%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- PAR
- Country
- FR
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- EUR
- Market Cap
- 150.2M
Opportunity signals
- Price is above the Trend Line, keeping the weekly tape constructive.
- Market Dynamics is positive on the latest completed week.
- Latest weekly return ranks in the strongest part of its sector group.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
- Recent volatility is running well above the one-year baseline.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 1.56 EUR | 1.4% | 1.45 EUR | 1.97 EUR | 0.95 | -4.08 | 636.5K | Off |
| 5 Jun 2026 | 1.54 EUR | -4.5% | 1.45 EUR | 1.98 EUR | 1.10 | -4.21 | 1.3M | Off |
| 29 May 2026 | 1.61 EUR | -1.7% | 1.45 EUR | 1.99 EUR | 0.90 | 0.12 | 2.4M | Off |
| 22 May 2026 | 1.64 EUR | -5.7% | 1.45 EUR | 2.00 EUR | 0.51 | 2.13 | 5.9M | Off |
| 15 May 2026 | 1.74 EUR | 38.8% | 1.46 EUR | 2.01 EUR | 0.03 | 10.03 | 6.3M | Off |
| 8 May 2026 | 1.25 EUR | 4.5% | 1.46 EUR | 2.01 EUR | -0.20 | -22.45 | 1.4M | Off |
| 1 May 2026 | 1.20 EUR | 7.1% | 1.48 EUR | 2.02 EUR | -0.52 | -26.58 | 1.2M | Off |
| 24 Apr 2026 | 1.12 EUR | -18.6% | 1.50 EUR | 2.03 EUR | -0.71 | -32.52 | 2.1M | Off |
| 17 Apr 2026 | 1.38 EUR | 18.4% | 1.51 EUR | 2.04 EUR | -0.90 | -20.44 | 3.4M | Off |
| 10 Apr 2026 | 1.16 EUR | 0.0% | 1.52 EUR | 2.05 EUR | -1.31 | -31.96 | 1.2M | Off |
| 3 Apr 2026 | 1.16 EUR | 5.6% | 1.54 EUR | 2.06 EUR | -1.33 | -30.06 | 1.2M | Off |
| 27 Mar 2026 | 1.10 EUR | 2.4% | 1.56 EUR | 2.08 EUR | -1.29 | -32.13 | 1.3M | Off |
| 20 Mar 2026 | 1.07 EUR | -14.1% | 1.58 EUR | 2.09 EUR | -1.21 | -33.97 | 1.4M | Off |
| 13 Mar 2026 | 1.25 EUR | -10.1% | 1.61 EUR | 2.10 EUR | -1.24 | -26.17 | 968.9K | Off |